| Product Code: ETC10772561 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Norway saw a significant increase in import shipments of peripheral intervention drug-eluting devices, with top exporting countries being the UK, Germany, USA, Denmark, and Metropolitan France. The Herfindahl-Hirschman Index (HHI) remained at a very low concentration level, indicating a competitive market landscape. The compound annual growth rate (CAGR) from 2020 to 2024 was steady at 3.86%, while the growth rate from 2023 to 2024 spiked at an impressive 27.79%. This data suggests a growing demand for these medical devices in Norway, with a diverse range of suppliers contributing to the market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Norway Peripheral Intervention Drug-Eluting Devices Market Overview |
3.1 Norway Country Macro Economic Indicators |
3.2 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Norway Peripheral Intervention Drug-Eluting Devices Market - Industry Life Cycle |
3.4 Norway Peripheral Intervention Drug-Eluting Devices Market - Porter's Five Forces |
3.5 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Device Type, 2021 & 2031F |
3.6 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Coating Material, 2021 & 2031F |
3.7 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Norway Peripheral Intervention Drug-Eluting Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of peripheral artery disease in Norway |
4.2.2 Technological advancements in drug-eluting devices for peripheral interventions |
4.2.3 Growing demand for minimally invasive procedures in the healthcare sector |
4.3 Market Restraints |
4.3.1 High costs associated with drug-eluting devices |
4.3.2 Stringent regulatory requirements for market approval |
4.3.3 Limited reimbursement policies for peripheral interventions in Norway |
5 Norway Peripheral Intervention Drug-Eluting Devices Market Trends |
6 Norway Peripheral Intervention Drug-Eluting Devices Market, By Types |
6.1 Norway Peripheral Intervention Drug-Eluting Devices Market, By Device Type |
6.1.1 Overview and Analysis |
6.1.2 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Device Type, 2021 - 2031F |
6.1.3 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Drug-Eluting Stents, 2021 - 2031F |
6.1.4 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Drug-Eluting Balloons, 2021 - 2031F |
6.1.5 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Biodegradable Stents, 2021 - 2031F |
6.1.6 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Polymer-Based Stents, 2021 - 2031F |
6.1.7 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Hybrid Coated Stents, 2021 - 2031F |
6.2 Norway Peripheral Intervention Drug-Eluting Devices Market, By Coating Material |
6.2.1 Overview and Analysis |
6.2.2 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Sirolimus, 2021 - 2031F |
6.2.3 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Paclitaxel, 2021 - 2031F |
6.2.4 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Everolimus, 2021 - 2031F |
6.2.5 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Zotarolimus, 2021 - 2031F |
6.2.6 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Rapamycin, 2021 - 2031F |
6.3 Norway Peripheral Intervention Drug-Eluting Devices Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Peripheral Artery Disease, 2021 - 2031F |
6.3.3 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Chronic Limb Ischemia, 2021 - 2031F |
6.3.4 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Deep Vein Thrombosis, 2021 - 2031F |
6.3.5 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Aneurysm Repair, 2021 - 2031F |
6.3.6 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Stenosis Treatment, 2021 - 2031F |
6.4 Norway Peripheral Intervention Drug-Eluting Devices Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.4 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Ambulatory Centers, 2021 - 2031F |
6.4.5 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.6 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Cardiac Care Centers, 2021 - 2031F |
6.5 Norway Peripheral Intervention Drug-Eluting Devices Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Nanocoating, 2021 - 2031F |
6.5.3 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Biodegradable Coating, 2021 - 2031F |
6.5.4 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Sustained Drug Release, 2021 - 2031F |
6.5.5 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Polymer-Encapsulated, 2021 - 2031F |
6.5.6 Norway Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Targeted Drug Delivery, 2021 - 2031F |
7 Norway Peripheral Intervention Drug-Eluting Devices Market Import-Export Trade Statistics |
7.1 Norway Peripheral Intervention Drug-Eluting Devices Market Export to Major Countries |
7.2 Norway Peripheral Intervention Drug-Eluting Devices Market Imports from Major Countries |
8 Norway Peripheral Intervention Drug-Eluting Devices Market Key Performance Indicators |
8.1 Average procedure time for peripheral interventions |
8.2 Number of new product launches in the drug-eluting devices market |
8.3 Adoption rate of drug-eluting devices in peripheral interventions |
8.4 Average length of hospital stay post peripheral intervention |
8.5 Rate of complications associated with drug-eluting devices in peripheral interventions |
9 Norway Peripheral Intervention Drug-Eluting Devices Market - Opportunity Assessment |
9.1 Norway Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Device Type, 2021 & 2031F |
9.2 Norway Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Coating Material, 2021 & 2031F |
9.3 Norway Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Norway Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Norway Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Norway Peripheral Intervention Drug-Eluting Devices Market - Competitive Landscape |
10.1 Norway Peripheral Intervention Drug-Eluting Devices Market Revenue Share, By Companies, 2024 |
10.2 Norway Peripheral Intervention Drug-Eluting Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here